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ABSTRACT 
 
Lignocellulosic biomass is an attractive source of renewable energy.  
Saccharomyces cerevisiae is often a biocatalyst of choice because of its ability to 
produce ethanol, as well as its robustness to harsh processing conditions.  However, by-
products from pretreatment and hydrolysis of biomass can have significant inhibitory 
effects on the growth of S. cerevisiae and biofuel production.  We utilize the 
visualization of evolution in real time (VERT) and genome shuffling to generate strains 
of S. cerevisiae with increased growth rates of up to 13% and 100% in the presence of 
the by-products furfural and 5-(hydroxymethyl) furfural, respectively. 
In addition to biofuel production, S. cerevisiae is also a major biocatalyst used 
for production of biochemicals.  The various products that it has been engineered to 
produce includes carotenoids, which has potential nutraceutical benefits.  We have 
previously developed an evolutionary engineering strategy that couples cell survival 
with increased carotenoids production and successfully developed carotenoids hyper-
producing strains.  Intercellular accumulation of the product has been observed in these 
strains, potentially limiting its production.  We attempt to use rational engineering to 
further improve the productivity of the hyper-producing strains by screening for 
carotenoids exporters that will potentially increase the driving force for carotenoids 
production and facilitate the development of a two-phase simultaneous fermentation and 
extraction system.  A variety of genes encoding plasma membrane ATP-binding cassette 
transporters were cloned into overexpression vectors and transformed into carotenoid-
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producing yeast.  Increased production of the carotenoid β-carotene was observed in a 
strain containing an overexpression vector for SNQ2. 
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1. INTRODUCTION  
 
 The yeast Saccharomyces cerevisiae (S. cerevisiae) has long been utilized as a 
biocatalyst to generate a multitude of products, ranging from biofuels to pharmaceuticals 
to food products.  The fermentation of renewable feedstock, particularly lignocellulosic 
biomass, using S. cerevisiae has tremendous potential to alleviate the world’s energy 
needs as we steadily deplete our sources of fossil fuels, and as more sustainable and 
environmentally responsible energy production becomes increasingly desirable [1, 2].  
Strains of S. cerevisiae have been engineered to produce simple biofuels, such as 
ethanol, and various fatty acid ethyl esters found in biodiesel [3, 4].  Metabolic 
engineering of these strains often requires overexpression of endogenous genes involved 
in the biosynthetic pathway of these products [5].  In contrast to this, many 
pharmaceutical and nutraceutical applications involve the heterologous expression of 
genes from other organisms.  The production of flavonoids, carotenoids, and Baccatin III 
have all been facilitated in S. cerevisiae by manipulation of the yeast genome to express 
proteins from other micro-organisms [6-8].  Dietary consumption of flavonoids has the 
potential to reduce the risk of cardiovascular disease.  Furthermore, the consumption of 
the carotenoid β-carotene has been reported to reduce the risk of certain cancers, and 
Baccatin III is a precursor of the anti-cancer drug, paclitaxel [8-10]. 
 The relative ease with which researchers are able to manipulate the genome of S. 
cerevisiae, the abundance of tools and information available on the organism, and its 
status as being generally regarded as safe, make it an attractive choice of biocatalyst. 
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However, many challenges in the production of chemicals using S. cerevisiae still need 
to be addressed in order to increase the economic viability of these processes.  For 
example, harsh fermentation conditions, the presence of toxic compounds, and physical 
limitations of the organism, can all contribute to low productivity and yield [11-13]. 
 My work focuses on overcoming challenges in two aspects of bio-based 
production in S. cerevisiae: the increase in tolerance to toxic hydrolysates present during 
fermentation of lignocellulosic biomass, and rational metabolic engineering of 
carotenoid hyper-producing strains of yeast for more efficient extracellular secretion. 
 Enhanced strains of S. cerevisiae have previously been engineered by Almario et 
al. for tolerance to hydrolysate by-products present in hydrolysates of lignocellulosic 
biomass [14].  Many of these strains contain vastly different mutational backgrounds.  
My work aims to utilize genome shuffling to create recombinants of these strains with 
further improved tolerance and to identify the mutations responsible for such observed 
phenotypes. 
 Strains of S. cerevisiae have also been engineered for the production of 
carotenoids in our lab [7].  Previous work by Reyes et al. have utilized adaptive 
laboratory evolution to increase carotenoid production.  However, further increase in 
productivity is still necessary for industrial application [11].  Intracellular accumulation 
of carotenoids have been observed in these strains, with miniscule levels of carotenoids 
observed in the surrounding growth media.  Some gene expression data from the same 
works suggest this accumulation may have toxic effects on yeast cells.  My work aims to 
amplify the expression of genes that may be involved in the trans-membrane transport of 
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carotenoids to alleviate these toxic effects and improve production.  Furthermore, 
extracellular export of the desired products may simplify down-stream processing for 
industrial application. 
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2. LITERATURE REVIEW 
 
2.1 Lignocellulosic Hydrolysates 
 
 A switch from fossil fuels to alternative energy sources is becoming increasingly 
desirable as the sources of such fuels are being depleted, and as the environmental 
consequences of global utilization of a non-sustainable energy sources becomes more 
apparent.  Renewable biofuel production shows great promise in attenuating our energy 
needs in an environmentally conscious way.  However, the use of food crops such as 
corn for such production poses ethical concerns in creating a tradeoff between food 
supply and energy generation.  The use of lignocellulosic biomass would forgo this 
issue, as well as contribute other ecological benefits: carbon sequestration in soil, 
minimal nitrous oxide emission, nitrogen and phosphorus conservation, and increased 
agricultural biodiversity [15, 16].  The ability of some lignocellulosic feed stocks to 
grow on otherwise marginalized lands can also decrease competition for land and 
increase the economic feasibility for biofuel production while minimizing habitat 
destruction and the carbon debt associated with land clearing for feedstock production 
[17]. 
 Lignocellulosic biomass is made up of three primary components: cellulose, 
hemicellulose, and lignin.  Cellulose is a straight-chain polysaccharide comprised 
completely of D-glucose subunits.  Hemicellulose is a highly branched polysaccharide 
containing a variety of hexose and pentose subunits.  Furthermore, the sugar backbone of 
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hemicellulose can contain acetyl side groups and other non-sugar compounds.  Lignin is 
a polymer containing a variety of aromatic alcohol subunits which can form a coating 
around the previously mentioned polysaccharides. 
 Biofuel production from lignocellulosic biomass requires pretreatment steps to 
convert polysaccharides into fermentable sugar monomers.  A common pretreatment 
method is dilute acid hydrolysis followed by enzymatic hydrolysis [18].  Dilute acid 
pretreatment serves to reduce the crystallinity of cellulose and to partially hydrolyze the 
polysaccharides.  Disrupting the ordered arrangement of the cellulose increases its 
porosity and effective surface area for further hydrolysis.  The acid treatment alone can 
hydrolyze some fraction polysaccharides, however to further increase monomeric 
conversion, acid treatment is typically followed by enzymatic catalysis with cellulases 
[19].  Pretreated biomass is then used as a feedstock and converted to biochemical or 
biofuel products through fermentation with a biocatalyst.   
 Dilute acid pretreatment, however, can generate a variety of undesirable by-
products.  Major classes of by-products present include furans, organic acids, and 
phenolics.  Pentose and hexose sugars can be hydrolyzed to furfural and 5-
(hydroxymethyl) furfural (HMF), respectively, making these the most abundant furans 
present after dilute acid hydrolysis as well as other pretreatment methods [20].  
Functional groups present on the sugar backbone of hemicellulose can also be liberated 
during pretreatment.  Significant amounts of acetylated hemicellulose results in high 
levels of acetic acid released during the pretreatment process. 
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2.2 Yeast Evolution 
 
 The baker’s yeast S. cerevisiae is used in numerous applications in academia as 
well as in industry.  Owing to its high productivity and yield, S. cerevisiae is often the 
biocatalyst of choice for the conversion of lignocellulosic biomass to ethanol [19]. 
However, a by-products present in pretreated lignocellulosic biomass can inhibit growth 
of S. cerevisiae and ethanol production[12].  In particular, HMF, furfural, and acetic acid 
can be present in inhibitory concentrations.  An increased level of tolerance to these 
inhibitors is desired as it may aid the proliferation of S. cerevisiae and ethanol 
production. 
 Adaptive laboratory evolution is a frequently utilized method in biotechnological 
engineering [21].  In adaptive laboratory evolution, organisms of interest are cultured in 
conditions that select for desired attributes.  Strains containing beneficial mutations 
outcompete other strains within the same population and can increase in frequency to 
dominate the population. Using this strategy, S. cerevisiae has been evolved by Almario 
et al. in the presence of lignocellulosic hydrolysates by serial passaging over many 
generations to allow for the selection of mutants with enhanced adaptation to 
hydrolysates of corn stover [14].   
 Evolutionary landscapes can be complex and an adaptive laboratory evolution 
experiment can contain more information than just the mutations that have fixed in the 
population at the end of the experiment.  In large populations, the probability of multiple 
beneficial mutations arising in independent lineages is high.  In asexually reproducing 
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populations, recombination between sub-populations with different beneficial mutations 
cannot occur, resulting in competition between these separate lineages.  In a phenomena 
termed clonal interference, these adept sub-populations compete with one another, and 
the less competitive sub-populations may be driven to extinction [22]. 
 The rational engineering of strains for desired traits requires knowledge on the 
genes and mechanisms involved, which makes adaptive laboratory evolution a powerful 
technique for use in inverse strain engineering.  The evolved mutants can be readily 
sequenced using next generation sequencing (NGS) technologies to identify the 
underlying mutations.  However, traditionally, strains are isolated from the end of, or 
periodically throughout, adaptive laboratory evolution experiments.  Any beneficial 
mutations that had become extinct prior to the points of sampling would not be 
identified.  To help alleviate this limitation, the Visualizing Evolution in Real-Time 
(VERT) method was developed by our lab.  In VERT, multiple fluorescent markers are 
used to track distinct lineages within the evolving population to characterize the growth 
dynamics of these independent sub-populations in evolution experiments [23].  S. 
cerevisiae was engineered to express either green, red, or yellow fluorescent proteins to 
generate three otherwise isogenic strains.  Equal proportions of these three strains are 
used to seed a bioreactor for adaptive laboratory evolution experiments.  The evolving 
population are then sampled regularly (e.g. daily) as the evolution experiment proceeds 
and then analyzed through fluorescence-activated cell sorting (FACS), quantifying the 
relative abundance of each labeled sub-population.  Observed expansions of a colored 
sub-population suggest the presence of an adaptive mutants within that sub-population; 
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such expansions are referred to as adaptive events.  The data generated allows for 
characterization of clonal interference events occurring between sub-populations and 
allows for more rational identification of generations that may contain useful 
information for subsequent molecular and phenotypic analysis. 
 In prior work, Almario et al. successfully evolved strains of S. cerevisiae that 
were tolerant to hydrolysates generated from dilute acid pretreated corn stover and 
utilized VERT to identify a number enhanced strains with different mutational 
backgrounds [14].  
 
2.3 Carotenoid Production in Yeast 
 
 Carotenoids belong to a broad class of chemical compounds.  Among those 
considered the most biologically significant to humans are lutein, lycopene, and the 
various forms of carotene.  The benefits associated with carotenoids are typically 
associated with their ability to mitigate the effects of reactive oxygen species [24].  
Carotenoids have been linked to reduced risk of lung cancer and cardiovascular disease, 
protection against skin damage from sun exposure, and have been used for cosmetics 
and food coloring [25-29].  β-carotene is also a precursor of vitamin A, and food crops 
fortified with β-carotene have been engineered to alleviate vitamin A deficiencies [30]. 
 Currently, carotenoids are produced through chemical synthesis or plant 
extraction [31].  However, production through microbial cell factories may be an 
attractive option to improve sustainability and economic feasibility.  A number of 
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microorganisms are naturally capable of producing carotenoids, but not at high enough 
yields to compete with alternative methods.  Among these organisms is the red yeast, 
Xanthophyllomyces dendrorhous.  The biosynthetic genes responsible for the production 
of carotenoids have been identified and successfully expressed in S. cerevisiae to 
produce greater amounts of carotenoids, specifically β-carotene [7]. 
 Since rational engineering of strains require a priori knowledge of the genes and 
mechanisms involved, it is likely that there exist gene(s) outside the direct carotenoids 
biosynthetic pathway that are important for the productivity of these compounds.  To 
further increase carotenoid production, Reyes et al. utilized adaptive laboratory 
evolution and VERT to generate carotenoid hyper-producing strains using hydrogen 
peroxide as a source of oxidative stress and selective pressure [11].  This strategy 
allowed us to couple carotenoid production with cell survival, owing to the anti-
oxidative properties of the desired compounds. 
 Microscopic inspection suggested that the vividly colored carotenoids are 
partitioning to the membranes of the cell, perhaps due to the hydrophobicity of the 
compounds.  Furthermore, analysis of a two phase liquid culture of media and dodecane 
exhibited very low levels of carotenoid secretion into the dodecane phase, suggesting 
intracellular localization. 
 Transcriptome analysis revealed an up-regulation of PDR3 in a number of the 
hyper-producing strains; PDR genes have been associated with transmembrane transport 
of toxic compounds and response to membrane damage via screening of overexpression 
using high copy-number plasmids or promoter induction, loss of function mutations, and 
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mutation mapping [32-36].  These data suggested that the accumulation of carotenoids 
within a cell may inhibit growth. 
 These observations suggest that extracellular export of carotenoids may serve to 
increase the driving force for carotenoid production as well as facilitate the downstream 
development of a two phase simultaneous fermentation and extraction system. 
 
2.4 Gene Targets for Carotenoid Export 
 
 A number of genes encoding plasma membrane ATP-binding cassette 
transporters that are associated with carotenoids have been previously annotated.  The 
genes PDR5, PDR15, and SNQ2 have been implicated in cellular responses to high 
levels of carotenoid production, and are thought to maintain membrane functionality via 
the export of toxic compounds [37].  STE6 is known to export the mating pheromone a-
factor only after its isoprenylation by carotenoid-like compounds [38].  YOR1 is known 
to export various organic compounds, and its overexpression in response to the 
terpenoid-phenol carvacrol has been observed [39].  In contrast, PDR11 facilitates the 
uptake of sterols when native ergosterol synthesis, which, like carotenoid synthesis is 
derivative of the mevalonate pathway, is compromised [40]. 
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3. MATERIALS AND METHODS 
 
3.1 Strains 
 
Table 1. Strains 
Name Relevant Features Source 
FY2 S. cerevisiae, MATα, ura3-52, S288C background Kao et al. 
[23] 
PG-132 S. cerevisiae, FY2 background, hydrolysate evolved 
mutant 
Almario et 
al. [14] 
PR-164 S. cerevisiae, FY2 background, hydrolysate evolved 
mutant 
Almario et 
al. [14] 
PG-259 S. cerevisiae, FY2 background, hydrolysate evolved 
mutant 
Almario et 
al. [14] 
PG-353 S. cerevisiae, FY2 background, hydrolysate evolved 
mutant 
Almario et 
al. [14] 
PR-438 S. cerevisiae, FY2 background, hydrolysate evolved 
mutant 
Almario et 
al. [14] 
GFP-RFP FY2 background diploid with GFP, RFP This work 
PG-132-RFP PG-132, FY2-RFP diploid This work 
PR-164-GFP PG-164, FY2-GFP diploid This work 
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Table 1. Continued 
Name Relevant Features Source 
PG-259-GFP PG-259, FY2-GFP diploid This work 
PG-353-RFP PG-353, FY2-RFP diploid This work 
PR-438-GFP PR-438, FY2-GFP diploid This work 
GSY1136 S. cerevisiae, S288C background, MATα, ura3-52, GAL+, 
YBR209W::Act1p-GFP-Act1t-URA3 
Kao et al. 
[23] 
YLH2 S. cerevisiae, GSY1136 background, carotenoid 
producing cassette YIplac211YB/I/E*, ΔCTT1 
Reyes et 
al. [11] 
SM14 S. cerevisiae, Hydrogen peroxide evolved strain, 
derivative of YLH2 
Reyes et 
al. [11] 
SM14-ATA SM14, pAG26::TDH3p::ACT1t This work 
SM14-ATA-Snq2 SM14, pAG26::TDH3p::SNQ2::ACT1t This work 
SM14-ATA-Ste6 SM14, pAG26::TDH3p::STE6::ACT1t This work 
SM14-ATA-Yor1 SM14, pAG26::TDH3p::YOR1::ACT1t This work 
BW25113  Laboratory strain of Escherichia Coli (E. coli) Datsenko 
et al. [41] 
BW-ATA BW25113, pAG26::TDH3p::ACT1t This work 
BW-ATA-Snq2 BW25113, pAG26::TDH3p::SNQ2::ACT1t This work 
BW-ATA-Ste6 BW25113, pAG26::TDH3p::STE6::ACT1t This work 
BW-ATA-Yor1 BW25113, pAG26::TDH3p::YOR1::ACT1t This work 
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 Table 1 contains strains and derivative strains used in this work. 
 
3.2 Materials 
 
 The yeast strains were cultured in yeast nitrogen base (YNB) containing 20 g/L 
dextrose, 1.7 g/L yeast nitrogen base (without amino acids or ammonium sulfate), 5 g//L 
ammonium sulfate, or yeast extract peptone dextrose (YPD) media containing 20 g/L 
dextrose, 10 g/L yeast extract, and 20 g/L peptone.  Sporulation of yeast was induced 
with the sporulation medium SPO++ containing 06.25 g/L yeast extract, 37.5 g/L 
potassium acetate, 450 mg/L adenine, 450 mg/L uracil, 450 mg/L tyrosine, 200 mg/L 
histidine, 200 mg/L leucine, 200 mg/L lysine, 200 mg/L tryptophan, 200 mg/L 
methionine, 200 mg/L arginine, 200 mg/L phenylalanine, 350 mg/L threonine, and 5g/L 
glucose. 
 E. coli strains were routinely cultured in Lysogeny broth (LB) media containing 
10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl.  Super optimal broth with 
catabolite repression (SOC) media containing 20 g/L tryptone, 5 g/L yeast extract, 0.5 
g/L NaCl, 0.186 g/L KCl, 0.952 g/L MgCl2, and 3.6 g/L dextrose was used during E. coli 
transformation. 
 For agar plates, the respective media was supplemented with 20 g/L agar.  
Cryogenically preserved strains were frozen at -80ºC in media and 17% (v/v) glycerol. 
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3.3 Primers and Plasmids 
 
Table 2. Primer Sequences for Cloning and Verification of Constructions.  Underlined 
sequences are cut sites for the enzymes in the name of the primer. 
 
Name Sequence (5’ 3’) Use 
SalI-ACT1t-f TCATGTCGACGTAGAAAAGGG
AGAGACAAAACACA 
Forward primer to amplify ACT1t from 
FY2, to amplify overlap PCR, and to 
verify ligation of genes to ACT1t 
AvrII-NheI-XbaI-
XhoI -ACT1t-r 
GTCTAGAGCTAGCCCCTAGGACAA
GAATACGACGAAAGTGGTCC 
Reverse primer to amplify 
ACT1t from FY2 
AscI-TDH3p-f TGAGGGCGCGCCCCAATACGCA
AACCGCCTCT 
Forward primer to amplify TDH3p 
from yEpGAP plasmid and to amplify 
overlap PCR 
AvrII-NheI-XbaI-
XhoI-TDH3p-r 
CCTAGGGGCTAGCTCTAGACTCGA
GGTCTACCTTCACCTTCACCTTCA 
Reverse primer to amplify 
TDH3p from yEpGAP plasmid 
XhoI-PDR5-f TGAGCTCGAGTGGCTGTTCGCT
TTTATTATCA 
Forward primer to amplify 
PDR5 from FY2 
NheI-PDR5-r TGAGGCTAGCTCCATTGCGTCC
TTTCTTTTT 
Reverse primer to amplify 
PDR5 from FY2 
XhoI-PDR11-f TGAGCTCGAGTCTAACGGAACG
CTATTCACTG 
Forward primer to amplify 
PDR11 from FY2 
NheI-PDR11-r TGAGGCTAGCTGCTGCGGTTTT
TGTTTGGC 
Forward primer to amplify 
PDR11 from FY2 
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Table 2. Continued 
Name Sequence (5’ 3’) Use 
XbaI-PDR15-f TGAGTCTAGAACACACACAAGC
AAACACACT 
Forward primer to amplify 
PDR15 from FY2 
AvrII-PDR15-r TGAGCCTAGGACGAAAAGAGC
CTGATGTTGAA 
Forward primer to amplify 
PDR15 from FY2 
XhoI-SNQ2-f TGAGCTCGAGACTATATCGAAG
ACCGAAAGCA 
Forward primer to amplify 
SNQ2 from FY2 
NheI-SNQ2-r TGAGGCTAGCTCTGAAGCCCAC
ATTACTGC 
Forward primer to amplify 
SNQ2 from FY2 
XhoI-STE6-f TGAGCTCGAGTGGGTTTAACTG
CTTTGGTTGGA 
Forward primer to amplify 
STE6 from FY2 
NheI-STE6-r TGAGGCTAGCAGAGCTTTCAAG
TGCCGCTG 
Forward primer to amplify 
STE6 from FY2 
XhoI-YOR1-f TGAGCTCGAGTCAAAAAGAGT
AAAGCCGTTGC 
Forward primer to amplify 
YOR1 from FY2 
NheI-YOR1-r TGAGGCTAGCAATGAAAAAGG
ACCGAAGGCGT 
Forward primer to amplify 
YOR1 from FY2 
PDR5-
verification-f 
AGAGTGCCTAAAAAGAACGGT Forward primer to verify 
ligation of PDR5 to ACT1t 
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Table 2. Continued 
Name Sequence (5’ 3’) Use 
PDR11-
verification-f 
ATTGAACGGTAGCCCCATCA Forward primer to verify 
ligation of PDR11 to ACT1t 
PDR15-
verification-f 
GGTATCCACCACCAATGCCT Forward primer to verify 
ligation of PDR15 to ACT1t 
SNQ2-
verification-f 
CAACCCACCAAACGGCTCAA Forward primer to verify 
ligation of SNQ2 to ACT1t 
STE6-
verification-f 
TGCCCGTCAGGATAGAAGTAA Forward primer to verify 
ligation of STE6 to ACT1t 
YOR1-
verification-f 
AGAAGGGTGAAGTCGCAGAA Forward primer to verify 
ligation of YOR1 to ACT1t 
PG-132.1-f GCCAGCTGATTCTCTTCTTAC Screening for mutations in 
diploids 
PG-132.1-r CAGACAAATGGAAGTGGGTTC Screening for mutations in 
diploids 
PG-132.2-f CTGCCCTTAATACATACGTTAT
AC 
Screening for mutations in 
diploids 
PG-132.2-r CATTGCTCTGAGGGCTCATAAC Screening for mutations in 
diploids 
PG-132.3-f TCCATTAACGACTTTGACGTC Screening for mutations in 
diploids 
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Table 2. Continued 
Name Sequence (5’ 3’) Use 
PG-132.3-r GCGTTTGTGACAAGAAGTAAT 
G 
Screening for mutations in 
diploids 
PG-132.4-f CAATGTCCAGTTGAGCCACC Screening for mutations in 
diploids 
PG-132.4-r CAGAAGAAGTATTCGAACTGA
GG 
Screening for mutations in 
diploids 
PG-164.1-f TGATCCCACCACCATGGTC Screening for mutations in 
diploids 
PG-164.1-r TGATCCCACCACCATGGTA Screening for mutations in 
diploids 
PG-259.1-f CGCTCTCATGGGTCAAGATAA  Screening for mutations in 
diploids 
PG-259.1-r AGGTAGAAGAGGGTCAGCAC Screening for mutations in 
diploids 
PG-259.2-f CTACGCATATGGTTTCAAGATC Screening for mutations in 
diploids 
PG-259.2-r GTACCACCAGTGGATTGCAC Screening for mutations in 
diploids 
PG-259.3-f GCCAGATCCAAAGTAGCCTTAG Screening for mutations in 
diploids 
 
 18 
 
Table 2. Continued 
Name Sequence (5’ 3’) Use 
PG-259.3-r CGATTGACACAGAGGCATGTTC Screening for mutations in 
diploids 
PG-259.4-f GCCTTCTGCCAAAGAGGTTAA Screening for mutations in 
diploids 
PG-259.4-r AGACATATTAGGCATCAGAGG Screening for mutations in 
diploids 
PG-259.5-f GCGCTAGGGTGAAGAGAGTTA Screening for mutations in 
diploids 
PG-259.5-r GTTGTTGGCGTGTGCATTT Screening for mutations in 
diploids 
PG-259.6-f GACATTGTTTCCGTAGCTTTA 
CC 
Screening for mutations in 
diploids 
PG-259.6-r TATGCACGCTCCACTTACTCC Screening for mutations in 
diploids 
PG-353.1-f TCTTGTTGGGCGAAAACAGAG Screening for mutations in 
diploids 
PG-353.1-f TGAAAATTATCCTGGGCTGCA Screening for mutations in 
diploids 
PR-438.1-f GACTTCAATACAGTCTTCGAAC
CAAA 
Screening for mutations in 
diploids 
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Table 2. Continued 
Name Sequence (5’ 3’) Use 
PR-438.1-r TCCTTATACAGCTGCTGTTACA
AT T 
Screening for mutations in 
diploids 
PR-438.2-f GACTTCAATACAGTCTTCGAAC
CAAC 
Screening for mutations in 
diploids 
PR-438.2-r TCCTTATACAGCTGCTGTTACA
AT T 
Screening for mutations in 
diploids 
 
 
 Table 2 contains various oligonucleotides used for genetic manipulation in these 
works. 
 The TDH3p (TDH3 promoter) sequence was amplified from the plasmid 
yEpGAP-cherry [42].  The yeast centromere plasmid pAG26 was the vector used for 
cloning [43]; it contains hygromycin resistance B marker (hph), ampicillin resistance 
marker (amp), and uracil biosynthesis marker (URA3).   
 
3.4 Mating 
 
 Standard yeast mating and zygote-pulling using a micro-dissection procedure 
were used to generate the heterozygous diploid strains of each evolved mutant PG-132, 
PG-259, PG-353, PR-164, and PR-438.  These haploid strains were mated with wild-
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type strains of FY2 marked with a different fluorescent proteins.  An FY2 strain with a 
GFP marker and a FY2 strain with an RFP marker were also mated to generate the GFP-
RFP reference diploid strain.  The strains to be mated were grown overnight in YPD 
media.  250 µl of the overnight culture of each strain were combined in a sterile 1.5 mL 
microcentrifuge tube.  10 µl of each mixed culture were spotted on YPD plate and 
incubated at 30ºC for two hours to allow mating.  A small portion of the cells were 
inspected under the microscope for zygote formation.  If the formation of zygotes was 
observed, at least five of these zygotes were pulled using a micromanipulator.  The 
resulting diploids were verified using flow cytometry (FACScan). Diploids products for 
each isolated mutant were named PG132-RFP, PG259-RFP, PR438-GFP, PR164-GFP 
and PG353-RFP.  Sporulation was induced with SPO++ media in separate test tubes for 
each diploid. Once sporulation was observed, the spore sacs were digested with 
zymolyase and the spore mixture from all five strains (PG132-RFP, PG259-RFP, 
PR438-GFP, PR164-GFP and PG353-RFP) were combined in one test tube. The 
resulting mixture was then plate on YPD plates at 30ºC to allow for massive mating  
overnight. 
 
3.5 Enrichment 
 
 After incubation, cells were transferred to a synthetic hydrolysate media with 
concentration of 1.44g/L HMF, 0.036g/L furfural and 14.4 mM acetic acid in YNB.  The 
cells were serially passaged daily in fresh synthetic hydrolysates for the course of three 
days.  On the fourth day, cells were plated on solid media of synthetic hydrolysates and 
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agar. Approximately 20 colonies that grew on plates were cultured with this synthetic 
hydrolysate media on a 96 well plate in a TECANTM Infinite M200 microplate reader.  
The four recombinants with the greatest specific growth rates were named PMM1, 
PMM2, PMM3, and PMM4. 
 
3.6 Growth Kinetics 
 
 The wild-type diploid GFP-RFP, the five hydrolysate evolved mutant diploids, 
and the four potential recombinants were revived from frozen stocks by plating on YPD 
agar plates and incubated at 30°C for approximately 70 hours.  At least four colonies per 
condition of each strain were chosen based on normal size and appearance and grown in 
test tubes for approximately 14 hours with 2mL of YNB media supplemented with 1% 
(w/v) glucose and the following conditions: (a) no hydrolysates, (b) 40mM acetic acid, 
(c) 0.7 g/L furfural, (d) 0.9 g/L HMF, (e) 8.8mM acetic acid, 0.022 g/L furfural, and 0.88 
g/L HMF.  These conditions were determined after observing growth in a gradient of 
concentrations (data not shown) and selecting concentrations high enough to inhibit 
growth of the GFP-FP but not completely prevent its growth.  For condition (e), relative 
amounts of each inhibitor chosen were based on the highest levels of each inhibitor 
previously observed in various batches of pretreated corn stover [14].  5 uL of each 
culture was used to inoculate 100 µL of fresh YNB media supplemented with 1% (w/v) 
glucose and the corresponding inhibitory condition.  Cultures were grown in 96 well 
plates with at least two technical replicates per biological replicate.    OD600 was 
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monitored every 10 minutes using a TECANTM Infinite M200 microplate reader at 30°C 
with a 2 mm orbital amplitude for up to 34 hours. 
 The specific growth rates were calculated by finding the maximum difference 
between the logs of two OD600 measurements seven data points apart and dividing by 
the elapsed time.  A least squared linear regression was applied to these seven data 
points.  If R2 values were greater than 0.997, the number of selected data points would 
expand by two and iteratively analyzed in this way until R2 dropped below the chosen 
threshold of 0.997.  The slope of the linear fit of the resulting data set was taken as the 
maximal specific growth rate.  If the R2 of the initial seven data points is less than 0.997, 
the number of selected data points would be expanded by two iteratively so long as 
expansion resulted in an increase in R2.  Outlying data points were detected by 
comparing specific growth rates calculated this way to the specific growth rate 
calculated by slope between the initial seven data points.  When outlying data points 
were detected, ranges for locating maximal differences were manually altered to avoid 
erroneous data.  When the iterative expansion of data points resulted in use of data from 
the latest time point in a TECAN run, growth curves were labeled as not reaching 
stationary phase. 
 The relative fitness coefficients were calculated for each strain using the 
following equation. 
𝛍𝐦𝐮𝐭𝐚𝐧𝐭𝐢
𝛍𝐰𝐢𝐥𝐝𝐭𝐲𝐩𝐞𝐢
− 𝟏 
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The symbol µ is the specific growth rate of the strain under the various inhibitory 
conditions.  A specific fitness coefficient was calculated with the following equation. 
(
µmutanti 
µmutant0
−
µwildtypei 
µwildtype0
)
µwildtypei 
µwildtype0
 
The subscripts “i” and “o” denote the presence of inhibitors or lack thereof, respectively. 
 
3.7 Genome Sequencing 
 
 The genomes of the original isolated evolved haploid mutants (PG-132, PG-259, 
PG-353, PR-164, and PR-438) were sequenced using Illumina HiSeq 2500 with 100 
base-pair single-end reads.  CLC Workbench was used to analyze the data using default 
threshold levels.  Each sequence was aligned to the reference S. cerevisiae strain S288C.  
The parental strain was also sequenced to eliminate any differences between the S288C 
strain used in our studies and the reference S288C sequence in the database.  Differences 
between the alignment of the parental strain and evolved strains were used to identify 
mutations and verified via Sanger sequencing. 
 
3.8 Construction of Yeast Strains with Transporter Overexpression Plasmids 
 
 S. cerevisiae strain FY2 was grown in YPD media for approximately 24 hours at 
30ºC with agitation.  Genomic DNA was isolated from these cells using ZR 
Fungal/Bacterial DNA MiniPrep™ kit (Zymo Research).  Genes of interest and the 
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ACT1 terminator (ACT1t) were PCR amplified from the wild-type genomic DNA using 
a high fidelity DNA polymerase and the corresponding primers, i.e. XhoI-PDR5-f and 
NheI-PDR5-r for PDR5 (Table 2).  The PCR products for each gene-of-interest were 
digested with corresponding enzymes, e.g. PDR5 was digested with XhoI and NheI.  The 
TDH3 promoter (TDH3p) was used to express the transporters and was amplified from 
plasmid yEpGAP-cherry using the primers AscI-TDH3p-f and AvrII-NheI-XbaI-XhoI-
TDH3p-r.  Overlap extension PCR was used to generate a construct containing the 
TDH3p and the ACT1t with a multiple cloning site between them (TDH3p::ACT1t).  
TDH3p::ACT1t and the plasmid pAG26 were digested with AscI and SalI and ligated 
with T4 DNA ligase.  The ligated product (pAG26::TDH3p::ACT1t) was transformed 
into the E. coli strain BW25113 using an electroporation protocol [44].  Cells were 
cultured in SOC media for approximately one hour and plated on LB agar plates 
supplemented with 100 µg/mL ampicillin.  Correct transformants were verified using 
colony PCR with AscI-TDH3p-f and SalI-ACT1t-r.  A successful transformant was 
cultured in LB media supplemented with 100 µg/mL ampicillin for approximately 24 
hours.  Plasmid DNA was isolated from these cells and digested with enzymes 
corresponding to the respect gene of interest, e.g. XhoI and NheI for PDR5, and then 
ligated with the corresponding gene of interest.  The ligated product was transformed 
into BW25113 and cultured as previously stated.  Transformants were verified using 
colony PCR with SalI-ACT1t-f and the corresponding verification primer, e.g. PDR5-
verification-f for PDR5.  The resulting plasmid was transformed into yeast strain SM14 
using the lithium acetate method with salmon sperm DNA, and PEG 3350 [45].  
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Transformants were selected for on YNB plates supplemented with 400 µg/mL 
Hygromycin B and verified with colony PCR as previously stated. 
 
3.9 Carotenoid Export 
 
 SM14-ATA, SM14-Snq2, SM14-Ste6, and SM14-Yor1 were cultured in a two-
phase liquid culture of 30 mL YPD overlayed with 15 mL of dodecane at 30°C for 
roughly three days.  200 µL of the dodecane phase was plated in a 96 well plates with 
opaque walls and a clear bottom.  Absorbances were measured in a TECANTM Infinite 
M200 microplate reader with wavelengths ranging from 350 nm to 550 nm in 2 nm 
intervals.  Relative amounts of carotenoids were estimated from the area under the 
spectral curve using the trapezoidal rule and compared to the reference strain SM14-
ATA.  β-carotene concentrations were quantified using a standard curve generated by β-
carotene obtained from Enzo Life Sciences (Supplementary Materials.) 
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4. RESULTS 
 
4.1 Yeast Tolerance to Lignocellulosic Hydrolysates 
 
Growth Rate in Presence of Inhibitors 
 
 Massive mating of our previously evolved mutants (PG-132, PG-259, PG-353, 
PR-164, and PR-438) allows for genetic recombination and has the potential to generate 
more fit recombinants.  Heterozygous diploids of each of the five previously evolved 
haploid strains of S. cerevisiae were generated by mating each haploid with a wild-type 
strain marked with a different fluorescent protein.  The resulting diploids were 
sporulated and mass mated to generate recombinants.  The resulting mating products 
were enriched through serial passage in media containing a mixture of HMF, furfural, 
and acetic acid.  The best performing strains were named PMM1, PMM2, PMM3, and 
PMM4. 
 These potential diploid recombinants were phenotypically characterized under a 
variety of conditions along with their parental heterozygous diploid strains (PG132-RFP, 
PG259-RFP, PR438-GFP, PR164-GFP and PG353-RFP).  None of the parental strains 
exhibited significant increase in specific growth rate relative to the wild-type GFP-RFP 
(Supplemental Material.)  PMM1 exhibited a 13% increase in fitness relative to GFP-
RFP in the presence of furfural (Figure 1).  PMM3 and PMM4 exhibited a 37% and 
100% increase in relative fitness in the presence of HMF, respectively.  PMM4 also 
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exhibited a 30% increase in relative fitness in the presence of a mixture of furfural, 
HMF, and acetic acid with a p-value of 0.056. 
  
 
 
Figure 1. Relative Fitness of Mating Products to Inhibitor Conditions.  Specific growth 
rates of each mating product relative to GFP-RFP in the presence of individual inhibitors 
and in a mixture of all three.  Asterisk indicates statistical significance between mating 
products and GFP-RFP with a P-value < 0.05 (two-tailed student’s t-test, unequal 
variances.)  Two asterisks indicate at least three replicates under this condition were 
unable to grow or unable to reach stationary phase within 34 hours. 
 
 
 To analyze whether these changes in specific growth rates were unique to their 
inhibitory condition, rather than a general increase in fitness, we calculated a specific 
fitness coefficient that compared the difference in growth rate with and without 
inhibition from the mutant strains to the wild-type diploid GFP-RFP (Figure 2).  PMM4 
exhibited the highest levels increase in specific growth rate under inhibition compared to 
growth without inhibition.  Its specific fitness coefficients are 1.06 and 0.43 in HMF and 
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the mixture of the three hydrolysates, respectively.  PMM1 and PMM3 exhibit lower 
levels of relative change in specific growth rates, with specific fitness coefficients of 
0.04 in furfural and 0.24 in HMF, respectively. 
 
 
 
Figure 2.   Specific Fitness Coefficients.  Change in growth rate with and without 
inhibition compared to the change in GFP-RFP. 
 
 
Genomic Analysis 
 
 The genomes of the parental haploid strains were sequenced with Illumina 
HiSeq.  Multiple mutations were found in each strain, relative to the wild-type parental 
strain.  Amongst the five strains, eight intergenic mutations were identified with five 
being single nucleotide polymorphisms (SNPs) and two being insertions of one or four 
base pairs (Supplemental Material.)  One of the SNPs occurred in an autonomously 
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replicating sequence, ARS300.  Nine different SNPs were found in coding regions, all of 
which were non-synonymous (Table 3). 
 
 
Table 3. Genes Containing Mutations 
PG-132 PR-164 PG-259 PG-353 PR-438 
ART10 PKP1 ESC2 ESC2 PKP1 
SMF1  FLC3 FLC3 COQ5 
  COQ6 COQ6  
  SMF1   
  YPR015C   
 
 Sanger sequencing was used to determine which mutations from the original 
evolved mutants are present in the recombinants (Table 4).  The results showed that all 
identified mutations in the recombinants occurred in coding regions and were non-
synonymous. 
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Table 4. Mutations in Mating Products 
 PG-132.2  
ARS300 
PG-132.3 
ART10 
PG132.4 
SMF1 
PG-259.5 
SMF1 
PMM1  Y Y Y 
PMM2 Y Y Y  
PMM3    Y 
PMM4 Y Y Y  
 
 
4.2 Carotenoid Export 
 
 Attempts to transform our carotenoid hyper-producing strain, SM14, with 
overexpression plasmids for PDR5, PDR11, and PDR15 failed after multiple attempts.  
Correct transformants containing overexpression plasmids for SNQ2, STE6, and YOR1, 
however, were successfully isolated.  These strains were cultured in YPD media 
overlayed dodecane.  Analysis of the organic phase revealed no statistically significant 
difference in total carotenoid concentration compared to the reference strain containing 
an empty plasmid, SM14-ATA (Supplementary Material).  SM14-ATA-Snq2 did, 
however, show a significant increase in β-carotene concentration with 4.0 ± 0.4 mg/L as 
compared to 3.0 ± 0.2 mg/L in the reference strain. 
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5. CONCLUSION 
 
 Genome shuffling between isolated mutants evolved in the presence of 
hydrolysates of corn stover generated three recombinants (PMM1, PMM3, and PMM4) 
with increased tolerance to inhibitors.  The increase in fitness exhibited by PMM4 in 
HMF was shown to be specific to the inhibitory condition, whereas the increase in 
fitness present in PMM1 and PMM3 in furfural and HMF, respectively, are likely 
attributed to a general increase in fitness.  Sequencing data reveals PMM1 and PMM4 
are likely progeny of PG-132 but neither carried over one of its intergenic mutations and 
furthermore PMM1 did not carry over the mutation occurring in ARS300.  PMM1 and 
PMM3 both contained a single mutation in SMF1 from the evolved mutant PG-259 but 
none of the other six mutations. 
 It is interesting to note that our best performing recombinant, PMM4, contains 
only mutations from the evolved mutant PG-132.  Amongst the evolved mutants used to 
generate the recombinants, PG-132 was isolated from the earliest population in the 
evolution experiment.  Furthermore, both PG-132 and PG-259 contain mutations in 
SMF1 that were present in all of our recombinants, however, the SNP present in PG-132 
occurs at a different base-pair than that of PG-259.  SMF1 is known to be involved in 
transport of divalent ions. 
 The engineered carotenoid producing strain SM14-ATA-Snq2 exhibited 
increased secretion of β-carotene.  Though not statistically significant based on the six 
technical replicates analyzed, this strain also had an 18% increase in total carotenoid 
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secretion as compared to the reference strain.  Further studies with more biological 
replicates are necessary to suggest an increase in total carotenoid secretion and to 
confirm the increase in β-carotene secretion. Additional work may be done to assess the 
level of transcription of their respective genes in the transformants, SM14-ATA-Snq2, 
SM14-ATA-Ste6, and SM14-ATA-Yor1, at an RNA level to verify overexpression.  
Failure to isolate transformants overexpressing PDR5, PDR11, and PDR15 is possibly 
due to toxicity caused by overexpression.  Further cloning with lower copy-number 
plasmids or weaker promoters may provide further insight into these three genes.  
Potential gene targets for further rational engineering include the other plasma 
membrane ATP-binding cassette transporters identified in yeast: PDR10, PDR12, 
PDR18, AUS1, MDL1, and MDL2.  In particular, an up-regulation of PDR10 and 
PDR18 in response to the presence of the terpenoid phenol carvacrol have been observed 
[46]. 
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 APPENDIX 
 
SUPPLEMENTARY MATERIALS 
 
 
 
 
 
Figure 3.  Fitness of Parental Strains Relative to GFP-RFP.  Two asterisks denotes that at 
least three replicates were unable to grow or unable to reach stationary phase within 34 
hours.  No fitness coefficients were statistically different than that of GFP-RFP with a P-
value < 0.05 (two-tailed student’s t-test, unequal variances.) 
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Figure 4.  Absorbance across Visible Carotenoid Spectra.  Carotenoid concentrations in 
the dodecane phase of bilayer culture were analyzed across wavelengths where 
carotenoids show characteristic absorbances. 
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Table 5.  Genome Sequencing Results 
Chrom
-osome 
Strain 
Number 
Position Ref Evo Type Gene Amino acid 
change 
II PG-132.1 353568 C A  Intergenic  
III PG-132.2 1158 G T  ARS300  
XII PG-132.3 905647 T A Missense ART10 Glu  Val 
XV PG-132.4 91152 A G Missense SMF1 Tyr  His 
II PG259.1 353563 C A  Intergenic  
IV PG259.2 1200461 A C Missense ESC2 Leu  Phe 
VII PG259.3 246244 C G Missense FLC3 Thr  Ser 
VII PG259.4 1003785 T C Missense COQ6 Asp  Gly 
VIII PG259.5 391764 - A Insertion Intergenic  
XV PG259.6 90569 G A Missense SMF1 Ser  Phe 
XVI PG259.7 590694 A G Missense YPR015C Ser  Pro 
IX PR-438.1 275180 C A Missense PKP1 Asp  Tyr 
XIII PR-438.2 50798 A C Missense COQ5 Phe  Val 
IX PR-164.1 275283 C A Missense PKP1 Asp  Tyr 
II PG-353.1 353553 C A  Intergenic  
IV PG-353.2 1200463 A C Missense ESC2 Leu  Phe 
VII PG-353.3 246244 C G Missense FLC3 Thr  Ser 
VII PG-353.4 1003785 T C Missense COQ6 Asp  Gly 
VIII PG-353.5 391764 - A Insertion Intergenic  
 
 
 
Table 6.  Carotenoid Quantification.  The area under the curve generated by absorbance 
data ranging from 350 nm to 550 nm were calculated using the trapezoidal rule. 
 
 
 
 
 
 
 
 
 
 
 
 Average Area Under Curve Standard Deviation 
SM14-ATA 23.11  1.72 
SM14-ATA-Snq2 25.17 1.63 
SM14-ATA-Ste6 19.84 0.97 
SM14-ATA-Yor1 18.98 0.78 
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Figure 5.  β-Carotene Standard Curve.  Generated with β-Carotene obtained from Enzo 
Life Sciences. 
 
 
Table 7.  Total Carotenoid Secretion.  Values are calculated from the area under the 
curve ranging from 350 nm to 550 nm wavelengths and normalized to the reference 
strain, SM14-ATA. 
 
 Relative Carotenoid Secretion Standard Deviation p-value 
SNQ2 1.179 0.227 0.06 
STE6 0.715 0.136 0.004 
YOR1 0.639 0.117 0.001 
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